Search Share Prices
AZN Shares - Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC
StockMarketWire.com - Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8000p (from 7700p).
Broker Forecast - UBS issues a broker note on AstraZeneca PLC
StockMarketWire.com - UBS today reaffirms its sell investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 5800p (from 5700p).
AstraZeneca to add $13bn product sales in next 5 years, says broker Liberum
Patent expiries have slowed Astra’s sales over the last few years, which retreated to $21bn in 2017, down from a peak of $34bn six years earlier Astra’s five new products to be delivered includes ...
FTSE 100 lifted by soft pound and resurgent AstraZeneca
Drugs giant AstraZeneca PLC (LON:AZN) was top of the tree, up 3.1% at 7,133p after what broker Liberum Capital called a strong third-quarter sales performance. “At the product level key cancer growth ...
NewsBreak: Astrazeneca's Diabetes Drug Farxiga Gets U.S. Approval
Investing.com -- AstraZeneca (LON:AZN) said Monday its Farxiga drug for reducing the risk of heart failure in type-2 diabetes patients had been approved for use in the U.S. by the Food and Drug ...